Tomorrow, the Senate Judiciary Committee is scheduled to be marking up several intellectual property bills that threaten to undermine intellectual property (IP) protections for innovators. American innovation, particularly in the biopharmaceutical industry, is vital to improving patient access to life-saving treatments and medications.
Read MoreThe Trade Alliance to Promote Prosperity today signed onto a coalition letter, initiated by the National Taxpayers Union, to the Speaker of the U.S. House of Representatives, Minority Leader of the U.S. House of Representatives, Majority Leader of the U.S. Senate, and Minority Leader of the U.S. Senate and copying the Secretary of the Treasury, Secretary of Commerce, and U.S. Trade Representative, warning that tariffs will harm American families and producers…
Read MoreThis morning, the America First Policy Institute (AFPI) published a new issue brief titled, Put Americans First by Ending Global Freeloading. In the brief, AFPI recommends the United States implement Most Favored Nation (MFN) drug policies in order to prevent the rest of the world from leeching off of American pharmaceutical innovation. While foreign countries freeloading off American innovation is a legitimate problem, simply importing foreign price controls into America’s healthcare system is not the answer…
Read MoreTrade Alliance to Promote Prosperity Executive Director Kent Kaiser, Ph.D., appeared on the UpFront Show on KLTF radio on March 13 to discuss tariffs, free trade, companies masquerading as American, and the new poll that the organization recently commissioned through Fabrizio Lee & Associates…
Read MoreThe Trade Alliance to Promote Prosperity was referenced in a recent Real Clear Defense column, “Trump’s Tariffs – History Has Lessons To Be Followed,” by Gregory T. Kiley, former senior professional staff member, Senate Armed Services Committee; and U.S. Air Force Officer…
Read MoreThe Trade Alliance to Promote Prosperity was referenced in a recent Real Clear Policy column, “Conservatives Hope Trump Tariff Announcement Leverages Better Trade Deals,” by Peter Mihalick, a former legislative director and counsel to former Reps. Barbara Comstock of Virginia and Rodney Blum of Iowa…
Read MoreThe Trade Alliance to Promote Prosperity (TAPP) today released a national survey of 1,000 registered voters conducted for the organization from February 12-16, 2025, by Fabrizio Lee & Associates…
Read MoreCurrently, the Inflation Reduction Act enforces price controls on drugs under two different timelines. Small molecule drugs that are approved as New Drug Applications (NDAs) become eligible for price controls after nine years. Large molecule drugs, known as biologics, become eligible after 13 years. This unequal treatment is known as the “pill penalty.”…
Read MoreTrade Alliance to Promote Prosperity Executive Director Kent Kaiser, Ph.D., appeared on WWTC AM's The Jack Tomczak Show on March 1 to discuss the country's current state of tariff policy…
Read MoreThe Trade Alliance to Promote Prosperity joined nearly two dozen groups in sending a letter to Congress urging passage of common sense legislation to reform some of the ways in which pharmacy benefit managers (PBMs) interact with government programs like Medicare and Medicaid…
Read MoreThe Inflation Reduction Act subjects “large-molecule” biologic therapies to price controls 13 years after FDA approval, but "small-molecule" medicines are subject to price controls after only 9 years, undermining patient care…
Read MoreOn February 4, Trade Alliance to Promote Prosperity Executive Director Kent Kaiser, Ph.D., penned an op-ed in the DC Journal discussing regulations that stifle U.S. innovation and their impact on the technological race against China…
Read MoreToday, U.S. Senate Democrats called on the new Trump Administration to continue Medicare drug price “negotiations” to lower costs, a scheme included in President Biden’s Inflation Reduction Act. The Trade Alliance to Promote Prosperity urges President Trump to say “NO!” to pursuing the IRA’s socialist prescription drug pricing scheme…
Read MoreIn his final days in office, President Biden is redoubling his efforts to inject a socialist prescription drug pricing scheme into the American healthcare market with the ostensible goal of reducing the cost of prescription drugs. Yet by doing so, he is jeopardizing the development of new miracle cures and treatments…
Read MoreTrade Alliance to Promote Prosperity Executive Director Kent Kaiser, Ph.D., recently penned an op-ed in the Western Journal highlighting the importance of President-elect Donald Trump’s economic prosperity plan, specifically when it comes to ensuring that China will follow U.S. trade laws…
Read MoreOn Friday, Trade Alliance to Promote Prosperity Executive Director Kent Kaiser, Ph.D., wrote a letter to several members of Congress urging them to pass S.2973 and S.3430 this year in order to reform pharmacy benefit managers (PBMs)…
Read MoreTAPP joins seventeen other organizations in sending a letter to Chairman Ron Wyden and Ranking Member Mike Crapo urging them to process new nominees…
Read MoreTrade Alliance to Promote Prosperity Executive Director Kent Kaiser, Ph.D., appeared on the Jack Tomczak Show on WWTC 1280 AM The Patriot in the Twin Cities to discuss China's Milwaukee Tool.
Read MoreTomorrow, the Senate Judiciary Committee will hold a mark-up on the Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act. As TAPP has said in the past, the PREVAIL Act, and similar legislation, is critical to the promotion of American innovation and the maintaining of our technological edge over foreign adversaries like China.
Read MoreTrade Alliance to Promote Prosperity Executive Director Kent Kaiser, Ph.D., recently wrote a letter to the editor of the Financial Times. The letter discusses three bipartisan trade policies that the new Trump administration should pursue: The Level the Playing Field 2.0 Act, the Protecting American Industry and Labor from International Trade Crimes Act, and the Uyghur Forced Labor Prevention Act.
Read More